Objective: Cardiac involvement has been increasingly recognized in patients with polycystic ovary syndrome (PCOS). Identification of the earliest asymptomatic impairment of left ventricular (LV) performance may be important in preventing progression to overt heart failure. Our aim was to investigate LV function with different echocardiographic techniques in patients with PCOS. Methods: Thirty patients with PCOS and 30 age and body mass index matched healthy subjects were enrolled to this cross-sectional observational study. All subjects underwent echocardiography for assessment of resting LV function as well as two-dimensional speckle tracking echocardiography (2D-STE) and real-time three-dimensional echocardiography (3D-Echo). Global longitudinal strain (GLS) was calculated from 3 standard apical views using 2D-STE. Student t-test, Chi-square test, Pearson's, and Spearman's correlation analysis were used for statistical analysis. Results: The early mitral inflow deceleration time (DT), isovolumetric relaxation time (IVRT) and E/Em ratio were increased in the PCOS group (p<0.05 for all). Waist-to-hip ratio, fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR) and low-density lipoprotein (LDL) levels were higher in PCOS group (p<0.05 for all). Significant correlation was observed between DT, IVRT and insulin value, HOMA-IR (p<0.05 for all). On 3D-Echo evaluation, none of the patients in both groups had LV systolic dysfunction with comparable LV ejection fraction and LV volumes. 2D-STE showed that GLS was significantly reduced in the PCOS group compared to control group (-16.78±0.56% vs. -18.36±1.04%, p<0.001). The GLS was found to be negatively correlated with waist-to-hip ratio and LDL values (p<0.05 for all). Conclusion: These results indicate that PCOS may be related to impaired LV systolic function detected by 2D-STE. In addition, PCOS may lead to diastolic dysfunction. Reduced GLS might be an early indicator of cardiac involvement in this patient population. (Anadolu Kardiyol Derg 2013; 13: 784-90) ÖZET Amaç: Polikistik over sendromlu (PKOS) hastalarda kardiyak tutulumun olduğu kabul edilmektedir. Asemptomatik sol ventrikül (SV) fonksiyonlarındaki bozulmanın erken tespiti kalp yetersizliğine gidişatın önlenmesinde önemli olabilir. Amacımız PKOS hastalarında farklı ekokardiyografik teknikler kullanarak SV fonksiyonlarını araştırmaktır. Yöntemler: Kesitsel ve gözlemsel calışmamıza, polikistik over sendromlu 30 hasta ve demografik özellikleri benzer 30 sağlıklı kadın dahil edildi. İstirahat SV fonksiyonlarının değerlendirilmesinde standart transtorasik ekokardiyografi yanında, iki boyutlu benek izleme ekokardiyografi (2B-BIE) ve üç boyutlu ekokardiyografi (3B-Eko) bakıldı. SV hacimleri ve ejeksiyon fraksiyonu ölçümü 3B-Eko ile yapıldı. Apikal görüntülerden 2B-BIE tekniği kullanılarak global longitüdinal strain (GLS) değerleri hesaplandı. İstatistiksel analizde; Student t-testi, Ki-kare testi, Pearson ve Spearman korelasyon analizleri kullanıldı. Bulgular: Polikistik over sendromlu hastalarda mitral E dalgası deselerasyon zamanı (DT), E/Em oranı ve izovolümetrik relaksasyon zamanının (IVRT) kontrol grubuna göre artmış olduğu görüldü (tümü için p<0,05). Bel-kalça oranı, açlık insülin, düşük dansiteli lipoprotein (LDL) ve insülin direnci (HOMA-IR) seviyeleri PCOS grubunda daha yüksek bulundu (tümü için p<0,05). DT ve IVRT ile açlık insülin düzeyi ve HOMA-IR arasında anlamlı korelasyon saptandı (tümü için p<0,05). 3B-Eko değerlendirmesinde her iki grubun SV sistolik fonksiyonlarının normal olmasına rağmen 2B-BIE ile bakılan GLS değerlerinin PKOS grubunda daha düşük olduğu (-16,78±%0,56 vs. -18,36±%1,04, p<0,001) gösterildi. GLS ile bel-kalça oranı ve LDL seviyesi arasında negatif korelasyon tespit edildi (p<0,05). Sonuç: Polikistik over sendromunun asemptomatik SV sistolik fonksiyon bozukluğu ile ilişkili olabileceği 2B-BIE ile gösterildi. Ayrıca PKOS diyastolik fonksiyon parametrelerini de bozabilmektedir. Azalmış GLS, PKOS'lu hastalarda kardiyak tutulumun erken göstergesi olarak kullanılabilir.
Introduction
Polycystic ovary syndrome (PCOS), characterized by chronic anovulation and hyperandrogenism, is a common diagnosis made in up to one in 15 of women of childbearing age (1, 2) . Given the high prevalence of the metabolic syndrome (MetS) among women with PCOS, they are assumed to be at increased risk for cardiovascular disease (CVD) (3) . It has been reported that women with clinical features of PCOS have lower 5-year cardiovascular event-free survival than women without clinical features of PCOS (4) . Therefore, this group of patients need close and thorough follow-up.
Accurate determination of left ventricular (LV) volume and ejection fraction (EF) is important for clinical decision-making and follow-up. Conventional echocardiography (C-Echo) is a noninvasive, quick, inexpensive and radiation free method to assess EF and LV volumes, however, it does not provide reliable, reproducible, and accurate measurements. C-Echo has used the method of disks to calculate LV volumes based on areas in only 2 imaging planes. The three dimensional echocardiography (3D-Echo) calculates the actual left ventricular volume based on the actual shape, not the geometrical assumptions so that it has a good reproducibility, even if in the heart cavity has deformation, segmental wall motion abnormalities. It is more accurate than C-Echo, and is close to the gold standard magnetic resonance imaging MRI (5, 6) .
Two-dimensional speckle tracking echocardiography (2D-STE) can assess global LV function and it is superior to EF measurement by being angle independent, less subject to artifact, and simpler to obtain than Doppler-derived tissue velocity imaging. Strain and strain rate imaging by a 2D-STE method is a novel echocardiographic technique for evaluation of regional and global myocardial function and is relatively free from angle dependency, frame-rate limitation of tissue Doppler imaging and is easier to calculate (7, 8) . Based on 2D-STE, automated function imaging is used for reflection of systolic LV function by assessment of LV global longitudinal strain (GLS). Longitudinal tissue deformation is evaluated by frame-by-frame tracking of individual speckles throughout the cardiac cycle. This imaging technique discriminates between active and passive myocardial motion and enables angle-independent quantification of myocardial deformation in 2 dimensions (9, 10).
Since patients with PCOS are assumed to be at increased risk for CVD, there is a need in defining the presence or extent of myocardial dysfunction in this category of patients. The assessment using 2D-STE may be useful for identifying the patients with subclinical LV dysfunction although LVEF is normal on conventional echocardiography (11) .
The aim of our study was to investigate and compare the changes in cardiac functions and myocardial contractility among the patients with and without PCOS who have preserved LV systolic function by 2D-STE.
Methods

Study design
This cross-sectional observational study was conducted by Cardiology Department at Bezmialem Vakıf University Faculty of Medicine Hospital between March and August 2012.
Patient population
Thirty patients with a diagnosis of PCOS aged younger than 40 year and 30 healthy women matched by age, BMI, heart rate and blood pressure were included in the study. All patients underwent physical examination, chest X-Ray, 12-lead electrocardiography (ECG) and transthoracic echocardiographic evaluation. Patients with any cardiovascular disorder including hypertension, diabetes mellitus, thyroid and renal diseases, hyper-cortisolism, use of oral contraceptives or other hormonal therapy within the prior 3 months, pregnancy or breast-feeding, hyper-prolactinemia, smoking, chronic alcohol consumption, or history of use of any medications in the last 3 months were excluded. Hypertension was excluded on the basis of a negative history, absence of antihypertensive treatment and normal blood pressure values (<140/90 mm Hg); diabetes mellitus was excluded on the basis of normal fasting glucose and a 75-g oral glucose tolerance test (OGTT); and subclinical hypothyroidism and renal impairment were excluded on the basis of normal TSH and creatinine levels, respectively. Women were studied in the early follicular phase (2-5 d) of the menstrual cycle or after 3 months of amenorrhea.
Subjects were informed regarding the purpose of the study and provided written informed consent. Investigations were in accordance with the Declaration of Helsinki and were approved by the local Ethics Committees.
Definitions PCOS was diagnosed according to the Rotterdam criteria in the presence of at least two of the following three features: oligoor anovulation, hyperandrogenism, and polycystic ovaries (12). The International Diabetes Federation (IDF) diagnostic criteria were used to establish the presence of the metabolic syndrome (MetS) (13) . According to the IDF definition, someone has the metabolic syndrome if she has central adiposity plus two or more of the following four factors: 1) raised concentration of triglycerides (TG): >150 mg/dL (1.7 mmol/L) or specific treatment for this lipid abnormality; 2) reduced concentration of high-density lipoprotein (HDL) cholesterol: <50 mg/dL (1.29 mmol/L) or specific treatment for this lipid abnormality; 3) raised blood pressure: systolic blood pressure >130 mm Hg or diastolic blood pressure >85 mm Hg or treatment of previously diagnosed hypertension; and 4) raised fasting plasma glucose concentration >100 mg/dL (5.6 mmol/L) or previously diagnosed type 2 diabetes.
Laboratory data
At baseline, in the morning after an overnight fast, venous blood was sampled for the plasma concentration of glucose, low-density lipoprotein (LDL) and HDL cholesterol, TG, and insulin. In each subject, the degree of insulin resistance was estimated at the baseline by homeostatic model assessment (HOMA) according to the method described by Matthews et al. (14) . In particular, an insulin resistance (IR) score (HOMA-IR) was computed with the formula: fasting Glucose (mg/dL) x fasting Insulin(µU/mL) / 405.
Conventional echocardiography
C-Echo was performed on the subjects at rest in the left lateral decubitus position with synchronized electrocardiography by 2 professional cardiologists who were blinded to the clinical data with a commercially available system (Philips iE33, Bothell, WA, USA) equipped with a broadband S5-1 transducer (frequency transmitted: 1.7 MHz; received: 3.4 MHz). Complete 2D, color, pulsed and continuous-wave Doppler examinations were performed according to standard techniques. Parasternal long-axis views were used to derive the M-Mode measurements of left atrial (LA) size, LV end-diastolic septal (IVST) and posterior wall thickness (PWT), and LV end-diastolic (LVDd) and end-systolic (LVDs) dimensions. LV mass (LVM) was calculated from 2D echocardiographic measurements by using Devereux formula: LVM=1.04×[(IVST+PWT+LVDd) 3 -(LVDd) 3 ]-13.6 and was indexed to body surface area (15) . LVH was defined as a left-ventricular mass index (LVMI) greater than 100 g/m 2 . LV fractional shortening (FS) was calculated as [(LVDd-LVDs)/ LVDd]×100. LVEF was calculated from LV volumes by the 3D-Echo. Body mass index (BMI) and body surface area were calculated according to standard formulas. Trans mitral pulsedwave Doppler velocities were recorded from the apical fourchamber view with Doppler sample placed between the tips of the mitral leaflets. Early (E) and late (A) diastolic wave velocities, E/A ratio, E deceleration time (DT), and isovolumetric relaxation time (IVRT), isovolumetric contraction time (IVCT) were measured from the mitral inflow profile. The myocardial early diastolic (Em), and late diastolic (Am) velocities were obtained at the septal mitral annulus by placing a tissue Doppler sample volume. The E/Em ratio was calculated. All echocardiographic measurements used in the analysis were averaged from 3 heart beats.
Two-dimensional speckle-tracking echocardiography
The endocardial borders were traced in the end-systolic frame of the 2D images from the 3 apical views. Four consecutive end-expiratory cardiac cycles using the high frame rate (50 Hz or more) harmonic imaging in each echocardiographic view were acquired. Speckles were tracked frame by-frame throughout the LV wall during the cardiac cycle and basal, mid, and apical regions of interest were created. The operator manually adjusted segments that failed to be tracked. Any segments that subsequently failed to be tracked were excluded. Any view in which 2 or more segments could not be tracked was not includ-ed in the analysis, and the remaining apical views were averaged to calculate GLS; otherwise, GLS was calculated as the mean strain of all 17 segments. All measurements were made blinded to other results and clinical details.
Real-time three-dimensional echocardiography Real-time 3D-Echo images were also obtained from (3D-Echo) an apical window with the patient in the same position as 2D-STE. Full-volume images were also gathered over 4 cardiac cycles using a matrix array transducer (×4 transducer, Philips iE33, Andover, MA, USA). Measurements of 3D-Echo volumes and 3D-EF were performed off-line. (QLAB workstation using 3D-Advanced Quantification, Philips).
Statistical analysis
Measured values are reported as mean±standard deviation, and statistical comparisons were performed using SPSS 15.0 statistics package (SPSS Inc, Chicago, IL, USA). The categorical and continuous variables between the two groups were compared using the Chi-square test and Student's t-test, respectively. GLS and velocities were compared using an independent two sample t-test. The correlation between variables (waist-tohip ratio, insulin, HOMA-IR, LDL, GLS, DT, IVRT) was tested using correlation analysis. Differences were considered significant at a p value of <0.05.
Results
Demographic and clinical results
Clinical characteristics and laboratory findings of patients included in the study are shown in Table 1 . Mean age of study population was 26.0±5.6 years with no difference between groups. There were no significant differences in the average heart rate, mean systolic and diastolic blood pressures. There were 6 patients with MetS in PCOS group and 4 in control group. The fasting glucose, HDL, TG, waist circumference and BMI were similar between two groups while waist-to-hip ratio, insulin, HOMA-IR and LDL levels were higher in PCOS group.
Echocardiographic results
The M-mode, 2D, 3D, pulse wave Doppler and tissue Doppler echocardiographic variables are shown in Table 2 . LV dimensions, wall thicknesses and LA dimension were not different between two groups. 3D-EF, 3D-Echo volumes and FS were similar among the groups. The DT (169.8±5.7 msec vs. 163.6±5.6 msec; p<0.001), and IVRT (79±7 msec vs. 73±6 msec; p=0.004) were longer in the group of patients with PCOS whereas both groups had similar IVCT, E and A velocities and E/A ratio. Among the tissue Doppler parameters, patients with PCOS had lower Em and higher E/Em ratio (8.46±1.71 vs. 7.44±1.66; p=0.04) suggesting impaired diastolic function in this group. Significant correlation was observed between DT, IVRT and fasting insulin value, HOMA-IR (Table 3) .
Speckle-tracking echocardiographic results and association of GLS with variables GLS was significantly reduced in the PCOS group compared to control group (p<0.001; Table 4 ). In the correlation analysis, GLS was not correlated with fasting insulin, HOMA-IR, fasting glucose, HDL, TG, waist circumference and BMI. However, GLS was found to be negatively correlated with hip-to-waist ratio and LDL values (Table 5) .
Feasibility, reproducibility of 2D-STE and 3D-Echo analysis
Speckle-tracking analysis was feasible in all our study population. Time required for speckle analysis was 133±24 seconds for PCOS group and 129±26 seconds for healthy subjects. Acquisition of 3D-Echo data and analysis took 126±37 seconds per patient.
Inter-and intra-observer variabilityies
Variability in the measurement of GLS was evaluated in 20 randomly selected patients. For intra-observer variability, the same observer measured GLS for each of the selected patients again 10 days later. The coefficients of variation of intra-observer variability for GLS were 3.5%, respectively. For the interobserver variability, a second independent observer repeated the analysis. The coefficients of variation of inter-observer variability for GLS were 3.6%, respectively.
Discussion
In this observational study was to analyze the changes in LV systolic function in patients with PCOS. We found that patients with PCOS have impaired LV systolic longitudinal function as compared to individuals without PCOS.
LV systolic function is the most commonly assessed by LVEF using C-Echo. However, this technique provides limited data because of challenges related to image quality, assumptions of LV geometry, and operator experience (7) (8) . 2D-STE is based on tracking of characteristic speckle patterns created by interference of ultrasound beams in the myocardium and its accuracy has been confirmed using sonomicrometry and MRI, tagging as reference methods (16) . The development of speckle tracking has advanced the measurement of longitudinal function of the entire ventricle rather than basal segments alone. It is thought that longitudinal contraction is a particular marker of subendocardial function, which may be disproportionately involved in subclinical disease (17) . In accordance to this, in the present study PCOS patients had normal LVEF on 3D-Echo, however impaired myocardial strain on 2D-STE, which might be an indicator of subclinical LV dysfunction in this population.
The HUNT study has investigated the normal strain value range in healthy subjects using tissue Doppler and 2D-STE (18) . The normal GLS value was found -17.4% (2.3) in females and -15.9% (2.3) in males and strain values were reported to be decreased with the increasing age. In addition, this study showed that strain was overestimated by the 2D-STE method (18.4%) compared with the combined method (17.4%). The mean age of females in HUNT study was 47.8 (13.6) and the strain value in females below 40 years old was -17.9 (2.1). In our study, the average age was 26±5 and the GLS detected by 2D-STE was lower in PCOS group (-16.78±0.56% vs.-18.36±1.04%, p<0.001). As compared to HUNT study, lower GLS values by 2D-STE in a younger population may suggest a subclinical LV systolic dysfunction in this patient group.
There is severe evidence that patients with polycystic ovary syndrome (PCOS) have increased cardiovascular risk compared with age-matched controls. It has been estimated that myocardial infarction is seven times more likely in patients with PCOS (19) , and cardiac catheterization studies have shown more extensive coronary artery disease in these patients than in women with normal ovaries (20) . This association is actually not surprising because of the higher incidence of obesity, impaired glucose tolerance, overt diabetes mellitus and MetS in this patient population (21) . MetS and diabetes mellitus are well known causes of CVD. In addition, obesity by itself is related to atherosclerosis, hypertension and prothrombotic complications (22, 23) . Many studies have shown that LDL is increased in women with PCOS (24). Wild et al. (25) found that increased waist/hip ratio and hirsutism were associated with confirmed coronary artery disease. In our study, MetS was detected six patients in PCOS group and four in control group. The fasting glucose, HDL, TG, waist circumference and BMI were similar between two groups while waist-to-hip ratio, insulin, HOMA-IR and LDL levels were higher in PCOS group.
The relative risk of heart failure is greater in obese women than men (26) . Obesity contributes to LV dysfunction in various mechanisms, including overproduction of cardioinhibitory cytokines, myocardial fibrosis via up-regulating some neuro-hormones (especially angiotensin II) and chronic volume overload through ventricles (27, 28) . However, in the present study there was no difference in BMI between two groups while waist-tohip ratio was higher in PCOS group, suggesting that the pathogenesis of impaired myocardial function in PCOS patients is not only dependent on BMI. Several previous studies have reported increased arterial stiffness in patients with PCOS related to higher prevalence of hypertension and endothelial dysfunction in these patients (29) . Increased stiffness in the central arteries could lead an increase in wall stress in LV cavity and disrupt the structure of longitudinal myocardial fibers, which would result in myocardial dysfunction. Although myocardial strain was impaired in PCOS patients in our study, LVEF measured by 3D echo did not show difference between two groups. In contrast to our study, Prelevic et al. (30) measured LVEF by 2D echocardiography and found that PCOS patients have significantly lower LVEF than normal controls. This difference might have resulted from the different methods used for LVEF measurement in two studies.
Results of the echocardiographic studies were controversial in patients with PCOS. Some previous studies, did not find any significant differences in certain C-Echo and tissue Doppler echocardiographic measures of cardiac function between patients with PCOS and healthy control subjects. EF, mitral E/A ratio, DT, IVRT, tissue Doppler profiles of patients with PCOS were similar to controls (31, 32) . However, detrimental effect of PCOS on the cardiovascular system is evident even in young women asymptomatic for cardiac disease. Orio et al. (33) reported that PCOS women had higher LA size, LVMI, lower LVEF and E/A ratio than controls. Also, subclinical impairment of LV systolic and diastolic function as indicated by lower peak strain, peak systolic strain rate, peak early diastolic strain rate, and peak early diastolic velocity was demonstrated in with PCOS and IR group (34) . In addition, Prelevic et al. (30) reported that systolic flow velocity is lower in PCOS than in age-matched control women, and there is an inverse relationship between serum fasting insulin and LV systolic outflow parameters; fur- thermore, increased insulin levels in PCOS are associated with decreased cardiac flow. In the present study, we found waistto-hip ratio, insulin, HOMA-IR, LDL levels were higher in PCOS group and GLS correlation with the hip-to-waist ratio, LDL values. Insulin resistance plays an important role in the development of PCOS and hyperinsulinemia is a cardinal feature of PCOS (35) . LV diastolic dysfunction is an early manifestation of cardiomyopathy and might be related to CVD, hypertension, IR, endothelial dysfunction and oxidative stress (36) . Tıraş et al. (37) reported an IVRT were higher in patients with PCOS and significant correlation between IR and LV diastolic function. In our study, mitral E-and A-waves were similar in both groups, and DT, IVRT and E/Em ratio were significantly increased in PCOS group reflecting a trend for diastolic dysfunction. In addition, significant correlation was observed between DT, IVRT and fasting insulin value, HOMA-IR. One would expect that IR in this patient population is also a contributor for development of LV dysfunction
Study limitations
Our study has some limitations. The first limitation of our study was the relatively small number of patients. The limited number of patients in this study may not represent the whole PCOS population. Second, we did the measurements with only longitudinal strain and radial or circumferential strain was not assessed. Third, BNP level was not assessed in the present study. Final, in this study, long-term clinical outcome data, such as cardiovascular event rates and survival assessment, were not part of the present study. However our study leads way in furthering the efforts to understand the connecting links between PCOS and heart disease. Large control studies are needed to understand and validate our results.
Conclusion
PCOS may be related to impaired LV systolic function detected by 2D-STE. In addition PCOS may lead to diastolic dysfunction. Reduced GLS might be an early indicator of cardiac involvement in this patient population. Early detection of asymptomatic impairment of LV systolic function could provide physicians to prevent progression to overt heart failure with counseling the patients to alter the risk profile.
